{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:47:18Z","timestamp":1787755638889,"version":"build-2784847793"},"reference-count":148,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jns.2005.08.017","type":"journal-article","created":{"date-parts":[[2006,4,27]],"date-time":"2006-04-27T15:37:09Z","timestamp":1146152229000},"page":"21-33","source":"Crossref","is-referenced-by-count":77,"title":["Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiple sclerosis"],"prefix":"10.1016","volume":"245","author":[{"given":"G. Stennis","family":"Watson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2005.08.017_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.imlet.2004.07.017","article-title":"New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"96","author":"Behi","year":"2005","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jns.2005.08.017_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1189\/jlb.0803402","article-title":"Anti-inflammatory and antiproliferative actions of PPAR-gamma agonists on T lymphocytes derived from MS patients","volume":"75","author":"Schmidt","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jns.2005.08.017_bib3","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1001\/archneur.58.10.1602","article-title":"Cognitive dysfunction in early-onset multiple sclerosis: a reappraisal after 10\u00a0years","volume":"58","author":"Amato","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib4","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00019052-200306000-00006","article-title":"Cognitive dysfunction in multiple sclerosis: a review of recent developments","volume":"16","author":"Bobholz","year":"2003","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib5","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(02)08431-3","article-title":"Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study","volume":"359","author":"Marrosu","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.08.017_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1191\/1352458504ms1087oa","article-title":"A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic","volume":"10","author":"Edwards","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2005.08.017_bib7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00125-002-0967-6","article-title":"Multiple sclerosis and type I diabetes","volume":"45","author":"Buzzetti","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.jns.2005.08.017_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2337\/diacare.21.4.518","article-title":"Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"21","author":"Harris","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2005.08.017_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2337\/diacare.20.3.438","article-title":"Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies","volume":"20","author":"Strachan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2005.08.017_bib10","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/archpsyc.56.6.527","article-title":"Decreased memory performance in healthy humans induced by stress-level cortisol treatment","volume":"56","author":"Newcomer","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jns.2005.08.017_bib11","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/WNL.63.11_suppl_5.S12","article-title":"A multimodal approach to managing the symptoms of multiple sclerosis","volume":"63","author":"Crayton","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib12","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(96)90807-7","article-title":"Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group","volume":"347","author":"Sadovnick","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.08.017_bib13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S1474-4422(04)00933-0","article-title":"Environmental risk factors in multiple sclerosis aetiology","volume":"3","author":"Marrie","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ana.410330309","article-title":"A population-based study of multiple sclerosis in twins: update","volume":"33","author":"Sadovnick","year":"1993","journal-title":"Ann Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2005.08.017_bib15","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1177\/135245850401000103","article-title":"Natural history of primary progressive multiple sclerosis","volume":"10","author":"Ebers","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2005.08.017_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jns.2005.03.014","article-title":"Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases","volume":"233","author":"Schwartz","year":"2005","journal-title":"J Neurol Sci"},{"issue":"Suppl 5","key":"10.1016\/j.jns.2005.08.017_bib17","doi-asserted-by":"crossref","first-page":"v12","DOI":"10.1007\/s00415-004-1504-y","article-title":"What do we know about the mechanism of action of disease-modifying treatments in MS?","volume":"251","author":"Hartung","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib18","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jns.2005.08.017_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.10206","article-title":"Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis","volume":"51","author":"Feinstein","year":"2002","journal-title":"Ann Neurol"},{"issue":"Pt 5","key":"10.1016\/j.jns.2005.08.017_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/brain\/120.5.865","article-title":"Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives","volume":"120","author":"Hohlfeld","year":"1997","journal-title":"Brain"},{"key":"10.1016\/j.jns.2005.08.017_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000079937","article-title":"Cognitive, but not mood dysfunction develops in multiple sclerosis during 7\u00a0years of follow-up","volume":"52","author":"Haase","year":"2004","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/jnnp.2004.045872","article-title":"Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis","volume":"76","author":"Deloire","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2005.08.017_bib23","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.0500073102","article-title":"Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats","volume":"102","author":"D'Intino","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.08.017_bib24","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1212\/01.WNL.0000146628.30692.15","article-title":"Treating cognitive deficits in multiple sclerosis: are we there yet?","volume":"63","author":"Doraiswamy","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib25","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/01.WNL.0000142989.09633.5A","article-title":"Donepezil improved memory in multiple sclerosis in a randomized clinical trial","volume":"63","author":"Krupp","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib26","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/brain\/awg284","article-title":"Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine","volume":"126","author":"Parry","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2005.08.017_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S1474-4422(05)00972-5","article-title":"Donepezil for memory impairment in multiple sclerosis","volume":"4","author":"Amato","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib28","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.2337\/diacare.26.11.3192","article-title":"Type 1 diabetes and multiple sclerosis: together at last","volume":"26","author":"Dorman","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2005.08.017_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0095-4543(05)70130-5","article-title":"The natural history of type 2 diabetes. Implications for clinical practice","volume":"26","author":"Ramlo-Halsted","year":"1999","journal-title":"Prim Care"},{"key":"10.1016\/j.jns.2005.08.017_bib30","first-page":"833","article-title":"Prevalence of diabetes and impaired fasting glucose in adults\u2014United States, 1999\u20132000","volume":"52","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jns.2005.08.017_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1464-5491.2005.01516.x","article-title":"Prevalence of undiagnosed type 2 diabetes and impaired fasting glucose in older British men and women","volume":"22","author":"Thomas","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.jns.2005.08.017_bib32","doi-asserted-by":"crossref","first-page":"M5","DOI":"10.1093\/gerona\/56.1.M5","article-title":"Diabetes in elderly adults","volume":"56","author":"Meneilly","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jns.2005.08.017_bib33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archinte.160.2.174","article-title":"Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group","volume":"160","author":"Gregg","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jns.2005.08.017_bib34","doi-asserted-by":"crossref","first-page":"M117","DOI":"10.1093\/geronj\/48.4.M117","article-title":"The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes","volume":"48","author":"Meneilly","year":"1993","journal-title":"J Gerontol"},{"key":"10.1016\/j.jns.2005.08.017_bib35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/1520-7560(2000)9999:9999<::AID-DMRR141>3.0.CO;2-X","article-title":"Why is learning and memory dysfunction in type 2 diabetes limited to older adults?","volume":"16","author":"Ryan","year":"2000","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jns.2005.08.017_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1600-0404.1999.tb01045.x","article-title":"Type-2 diabetes and cognitive function in a non-demented population","volume":"100","author":"Vanhanen","year":"1999","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2005.08.017_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2337\/diacare.13.1.16","article-title":"Relationship between hyperglycemia and cognitive function in older NIDDM patients","volume":"13","author":"Reaven","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2005.08.017_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/1056-8727(95)00106-9","article-title":"Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control","volume":"11","author":"Naor","year":"1997","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jns.2005.08.017_bib39","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1532-5415.1993.tb06480.x","article-title":"Verbal learning and\/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus","volume":"41","author":"Gradman","year":"1993","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jns.2005.08.017_bib40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2005.08.017_bib41","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1212\/01.WNL.0000140292.04932.87","article-title":"Hyperinsulinemia and risk of Alzheimer disease","volume":"63","author":"Luchsinger","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib42","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2337\/diacare.21.3.398","article-title":"Cognitive function in an elderly population with persistent impaired glucose tolerance","volume":"21","author":"Vanhanen","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2005.08.017_bib43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1037\/0735-7044.113.3.431","article-title":"Effect of glucose, glucose regulation, and word imagery value on human memory","volume":"113","author":"Messier","year":"1999","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib44","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1212\/WNL.42.5.991","article-title":"Life expectancy in patients attending multiple sclerosis clinics","volume":"42","author":"Sadovnick","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2004.04.019","article-title":"Corticosteroids treatment","volume":"223","author":"Pozzilli","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2005.08.017_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2005.03.006","article-title":"Steroids and brain atrophy in multiple sclerosis","volume":"233","author":"Zivadinov","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2005.08.017_bib47","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI111141","article-title":"An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects","volume":"72","author":"Pagano","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2005.08.017_bib48","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0404.1998.tb05967.x","article-title":"Pulsed methylprednisolone induces a reversible impairment of memory in patients with relapsing\u2013remitting multiple sclerosis","volume":"97","author":"Oliveri","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2005.08.017_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1212\/01.WNL.0000149523.35039.4C","article-title":"Effect of corticosteroids on short-term and long-term memory","volume":"64","author":"Brunner","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib50","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0149-7634(00)00040-3","article-title":"Insulin receptors and insulin action in the brain: review and clinical implications","volume":"24","author":"Schulingkamp","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jns.2005.08.017_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.02.048","article-title":"Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease","volume":"490","author":"Watson","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2005.08.017_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.1104344","article-title":"Diabetes, obesity, and the brain","volume":"307","author":"Schwartz","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jns.2005.08.017_bib53","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1474-4422(04)00681-7","article-title":"Insulin and neurodegenerative disease: shared and specific mechanisms","volume":"3","author":"Craft","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2005.08.017_bib54","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1172\/JCI116773","article-title":"Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain","volume":"92","author":"Baura","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jns.2005.08.017_bib55","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0196-9781(97)00198-8","article-title":"Selective, physiological transport of insulin across the blood\u2013brain barrier: novel demonstration by species-specific radioimmunoassays","volume":"18","author":"Banks","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.jns.2005.08.017_bib56","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0196-9781(97)00231-3","article-title":"Transport of insulin across the blood\u2013brain barrier: saturability at euglycemic doses of insulin","volume":"18","author":"Banks","year":"1997","journal-title":"Peptides"},{"key":"10.1016\/j.jns.2005.08.017_bib57","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF Abeta42 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib58","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jcem-64-1-190","article-title":"Cerebrospinal fluid insulin levels increase during intravenous insulin infusions in man","volume":"64","author":"Wallum","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jns.2005.08.017_bib59","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/diabetes.49.9.1525","article-title":"Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs","volume":"49","author":"Kaiyala","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2005.08.017_bib60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0196-9781(90)90044-6","article-title":"Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats","volume":"11","author":"Schwartz","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/j.jns.2005.08.017_bib61","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.1070058","article-title":"Ablation of insulin-producing neurons in flies: growth and diabetic phenotypes","volume":"296","author":"Rulifson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jns.2005.08.017_bib62","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1016\/S0021-9258(17)37214-9","article-title":"Insulin gene expression and insulin synthesis in mammalian neuronal cells","volume":"269","author":"Devaskar","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2005.08.017_bib63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1210\/endo-123-1-505","article-title":"Insulin synthesis by isolated rabbit neurons","volume":"123","author":"Schechter","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.jns.2005.08.017_bib64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0167-0115(96)02120-9","article-title":"Insulin gene expression in immortalized rat hippocampal and pheochromocytoma-12 cell lines","volume":"69","author":"Singh","year":"1997","journal-title":"Regul Pept"},{"key":"10.1016\/j.jns.2005.08.017_bib65","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1073\/pnas.75.11.5737","article-title":"Identification of insulin in rat brain","volume":"75","author":"Havrankova","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.08.017_bib66","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/272827a0","article-title":"Insulin receptors are widely distributed in the central nervous system of the rat","volume":"272","author":"Havrankova","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.jns.2005.08.017_bib67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0301-0082(91)90015-S","article-title":"Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects","volume":"36","author":"Unger","year":"1991","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.jns.2005.08.017_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev.ph.49.030187.002003","article-title":"Insulin in the brain","volume":"49","author":"Baskin","year":"1987","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jns.2005.08.017_bib69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1037\/0033-295X.99.2.195","article-title":"Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans","volume":"99","author":"Squire","year":"1992","journal-title":"Psychol Rev"},{"key":"10.1016\/j.jns.2005.08.017_bib70","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson's disease. First of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jns.2005.08.017_bib71","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0031-9384(99)00220-6","article-title":"Intracerebroventricular insulin enhances memory in a passive-avoidance task","volume":"68","author":"Park","year":"2000","journal-title":"Physiol Behav"},{"key":"10.1016\/j.jns.2005.08.017_bib72","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","article-title":"Insulin dose\u2013response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype","volume":"28","author":"Craft","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jns.2005.08.017_bib73","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archpsyc.56.12.1135","article-title":"Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose","volume":"56","author":"Craft","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jns.2005.08.017_bib74","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0197-4580(95)02002-0","article-title":"Memory improvement following induced hyperinsulinemia in Alzheimer's disease","volume":"17","author":"Craft","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib75","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/nn0602-849","article-title":"Sniffing neuropeptides: a transnasal approach to the human brain","volume":"5","author":"Born","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib76","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neurobiolaging.2005.03.016","article-title":"Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype","volume":"27","author":"Reger","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib77","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2005.08.017_bib78","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diabetes.48.3.557","article-title":"Central nervous system effects of intranasally administered insulin during euglycemia in men","volume":"48","author":"Kern","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2005.08.017_bib79","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","article-title":"Intranasal insulin improves memory in humans","volume":"29","author":"Benedict","year":"2004","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jns.2005.08.017_bib80","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00023210-200317010-00003","article-title":"The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment","volume":"17","author":"Watson","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jns.2005.08.017_bib81","doi-asserted-by":"crossref","first-page":"34893","DOI":"10.1074\/jbc.274.49.34893","article-title":"Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats","volume":"274","author":"Zhao","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2005.08.017_bib82","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1073\/pnas.051634698","article-title":"Insulin promotes rapid delivery of N-methyl-d-aspartate receptors to the cell surface by exocytosis","volume":"98","author":"Skeberdis","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.08.017_bib83","series-title":"Fundamental neuroscience","first-page":"1276","article-title":"Learning and memory: basic mechanisms","author":"Byrne","year":"2003"},{"key":"10.1016\/j.jns.2005.08.017_bib84","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s001250051217","article-title":"NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats","volume":"42","author":"Di Luca","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/j.jns.2005.08.017_bib85","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO;2-X","article-title":"Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain","volume":"57","author":"Apelt","year":"1999","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.jns.2005.08.017_bib86","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1073\/pnas.051629798","article-title":"Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats","volume":"98","author":"Reagan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.08.017_bib87","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.2337\/diabetes.51.12.3384","article-title":"The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study","volume":"51","author":"Bingham","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2005.08.017_bib88","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0091-3057(97)00064-6","article-title":"Effect of combinations of insulin, glucose and scopolamine on radial arm maze performance","volume":"58","author":"Blanchard","year":"1997","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.jns.2005.08.017_bib89","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0361-9230(93)90210-3","article-title":"The effect of insulin on norepinephrine uptake by PC12 cells","volume":"32","author":"Figlewicz","year":"1993","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jns.2005.08.017_bib90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(93)90258-O","article-title":"Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus","volume":"602","author":"Figlewicz","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2005.08.017_bib91","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.neurobiolaging.2004.11.011","article-title":"Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease","volume":"27","author":"Watson","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib92","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu\u2013Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2005.08.017_bib93","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1749-6632.1997.tb48496.x","article-title":"The risk of dementia among persons with diabetes mellitus: a population-based cohort study","volume":"826","author":"Leibson","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2005.08.017_bib94","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib95","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/ageing\/23.5.396","article-title":"Hyperinsulinaemia and Alzheimer's disease","volume":"23","author":"Razay","year":"1994","journal-title":"Age Ageing"},{"key":"10.1016\/j.jns.2005.08.017_bib96","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1159\/000054469","article-title":"Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender","volume":"70","author":"Craft","year":"1999","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.jns.2005.08.017_bib97","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0531-5565(03)00153-0","article-title":"Diabetes, Alzheimer's disease and apolipoprotein genotype","volume":"38","author":"Messier","year":"2003","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jns.2005.08.017_bib98","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s007020200082","article-title":"The aging brain. Changes in the neuronal insulin\/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review","volume":"109","author":"Hoyer","year":"2002","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2005.08.017_bib99","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s007020050068","article-title":"Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease","volume":"105","author":"Frolich","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2005.08.017_bib100","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1523\/JNEUROSCI.21-08-02561.2001","article-title":"Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling","volume":"21","author":"Gasparini","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib101","doi-asserted-by":"crossref","first-page":"11120","DOI":"10.1523\/JNEUROSCI.2860-04.2004","article-title":"Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention","volume":"24","author":"Zhao","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib102","first-page":"149","article-title":"Insulin-degrading enzyme","volume":"19","author":"Authier","year":"1996","journal-title":"Clin Invest Med"},{"key":"10.1016\/j.jns.2005.08.017_bib103","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/bi011193l","article-title":"Differential effects of proteases involved in intracellular degradation of amyloid beta-protein between detergent-soluble and -insoluble pools in CHO-695 cells","volume":"41","author":"Sudoh","year":"2002","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.jns.2005.08.017_bib104","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1007527721160","article-title":"Degradation of soluble amyloid beta-peptides 1\u201340, 1\u201342, and the Dutch variant 1\u201340Q by insulin degrading enzyme from Alzheimer disease and control brains","volume":"25","author":"Perez","year":"2000","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2005.08.017_bib105","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.08.017_bib106","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)63822-9","article-title":"Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele","volume":"162","author":"Cook","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jns.2005.08.017_bib107","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1126\/science.290.5500.2304","article-title":"Susceptibility locus for Alzheimer's disease on chromosome 10","volume":"290","author":"Myers","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jns.2005.08.017_bib108","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1126\/science.290.5500.2303","article-title":"Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees","volume":"290","author":"Ertekin-Taner","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jns.2005.08.017_bib109","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1126\/science.290.5500.2302","article-title":"Evidence for genetic linkage of Alzheimer's disease to chromosome 10q","volume":"290","author":"Bertram","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.jns.2005.08.017_bib110","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00439-001-0614-1","article-title":"Substantial linkage disequilibrium across the insulin-degrading enzyme locus but no association with late-onset Alzheimer's disease","volume":"109","author":"Abraham","year":"2001","journal-title":"Hum Genet"},{"key":"10.1016\/j.jns.2005.08.017_bib111","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1212\/01.WNL.0000091890.32140.8F","article-title":"Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk","volume":"61","author":"Mayeux","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib112","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11892-002-0019-0","article-title":"Endothelium, inflammation, and diabetes","volume":"2","author":"Dandona","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jns.2005.08.017_bib113","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1152\/ajpendo.00274.2003","article-title":"Insulin stimulates interleukin-6 and tumor necrosis factor-alpha gene expression in human subcutaneous adipose tissue","volume":"286","author":"Krogh-Madsen","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jns.2005.08.017_bib114","doi-asserted-by":"crossref","first-page":"E1276","DOI":"10.1152\/ajpendo.00535.2001","article-title":"Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans","volume":"282","author":"Soop","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jns.2005.08.017_bib115","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2337\/diabetes.40.10.1223","article-title":"Insulin, prostaglandins, and the pathogenesis of hypertension","volume":"40","author":"Axelrod","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2005.08.017_bib116","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0014-2999(99)00407-0","article-title":"F2-Isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of vitamin E","volume":"377","author":"Laight","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jns.2005.08.017_bib117","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0891-5849(00)00438-X","article-title":"Hyperinsulinemia: the missing link among oxidative stress and age-related diseases?","volume":"29","author":"Facchini","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jns.2005.08.017_bib118","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s11892-004-0074-9","article-title":"Endothelial dysfunction, inflammation, and insulin resistance: a focus on subjects at risk for type 2 diabetes","volume":"4","author":"Caballero","year":"2004","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jns.2005.08.017_bib119","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer's disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib120","doi-asserted-by":"crossref","first-page":"510","DOI":"10.5858\/2001-125-0510-CFATAF","article-title":"Cerebrospinal fluid abeta42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls","volume":"125","author":"Montine","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jns.2005.08.017_bib121","doi-asserted-by":"crossref","first-page":"529","DOI":"10.2174\/1389450043345308","article-title":"Cytokines in neuroinflammation and Alzheimer's disease","volume":"5","author":"Cacquevel","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jns.2005.08.017_bib122","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1023\/A:1020568013953","article-title":"Intracerebral production of tumor necrosis factor-alpha, a local neuroprotective agent, in Alzheimer disease and vascular dementia","volume":"19","author":"Tarkowski","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jns.2005.08.017_bib123","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2005.08.017_bib124","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1023\/A:1022337519035","article-title":"The induction of the TNFalpha death domain signaling pathway in Alzheimer's disease brain","volume":"28","author":"Zhao","year":"2003","journal-title":"Neurochem Res"},{"key":"10.1016\/j.jns.2005.08.017_bib125","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.4049\/jimmunol.162.4.2154","article-title":"Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases","volume":"162","author":"Aggarwal","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2005.08.017_bib126","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2337\/diacare.26.3.875","article-title":"Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance","volume":"26","author":"Dzienis-Straczkowska","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2005.08.017_bib127","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1463-1326.2000.00090.x","article-title":"Variations in plasma soluble tumour necrosis factor receptors after diet-induced weight loss in obesity","volume":"2","author":"Bastard","year":"2000","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jns.2005.08.017_bib128","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","article-title":"Interleukin-1, neuroinflammation, and Alzheimer's disease","volume":"22","author":"Mrak","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib129","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nbd.2004.12.013","article-title":"Differential effects of oligomeric and fibrillar amyloid-beta 1\u201342 on astrocyte-mediated inflammation","volume":"18","author":"White","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jns.2005.08.017_bib130","doi-asserted-by":"crossref","first-page":"10075","DOI":"10.1073\/pnas.89.21.10075","article-title":"Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta\/A4 amyloid protein precursor","volume":"89","author":"Buxbaum","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jns.2005.08.017_bib131","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0197-4580(01)00294-9","article-title":"Genetics of interleukin 6: implications for Alzheimer's disease","volume":"22","author":"Papassotiropoulos","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib132","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1523\/JNEUROSCI.22-07-02434.2002","article-title":"Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer's disease","volume":"22","author":"Heneka","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib133","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","article-title":"Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease","volume":"1","author":"Bondareff","year":"1987","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jns.2005.08.017_bib134","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2003.01767.x","article-title":"PPARgamma and metabolism: insights from the study of human genetic variants","volume":"59","author":"Gurnell","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2005.08.017_bib135","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"Ferre","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2005.08.017_bib136","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1212\/WNL.50.1.164","article-title":"Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype","volume":"50","author":"Craft","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.08.017_bib137","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2005.08.017_bib138","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo","volume":"20","author":"Heneka","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib139","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0006-8993(01)03242-5","article-title":"Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons","volume":"924","author":"Uryu","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2005.08.017_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(02)02480-0","article-title":"Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2","volume":"941","author":"Kim","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.jns.2005.08.017_bib141","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1046\/j.1471-4159.2003.02045.x","article-title":"15-deoxy-delta12,14-prostaglandin J2 regulates the functional state and the survival of microglial cells through multiple molecular mechanisms","volume":"87","author":"Bernardo","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.jns.2005.08.017_bib142","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jneuroim.2004.12.015","article-title":"Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis","volume":"161","author":"Storer","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2005.08.017_bib143","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0197-4580(01)00296-2","article-title":"Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease","volume":"22","author":"Landreth","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2005.08.017_bib144","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib145","doi-asserted-by":"crossref","first-page":"9796","DOI":"10.1523\/JNEUROSCI.23-30-09796.2003","article-title":"Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase","volume":"23","author":"Sastre","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.jns.2005.08.017_bib146","doi-asserted-by":"crossref","first-page":"31825","DOI":"10.1074\/jbc.M303588200","article-title":"The non-cyclooxygenase targets of non-steroidal anti-inflammatory drugs, lipoxygenases, peroxisome proliferator-activated receptor, inhibitor of kappa B kinase, and NF kappa B, do not reduce amyloid beta 42 production","volume":"278","author":"Sagi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2005.08.017_bib147","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.4049\/jimmunol.168.5.2508","article-title":"Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis","volume":"168","author":"Diab","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2005.08.017_bib148","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-1-3","article-title":"Effect of pioglitazone treatment in a patient with secondary multiple sclerosis","volume":"1","author":"Pershadsingh","year":"2004","journal-title":"J Neuroinflamm"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T06:39:21Z","timestamp":1683441561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":148,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0022510X06000955"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.08.017","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}